BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38326746)

  • 41. Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease.
    Manning PM; Hamilton G; Wang K; Park C; Hooker JC; Wolfson T; Gamst A; Haufe WM; Schlein AN; Middleton MS; Sirlin CB
    Abdom Radiol (NY); 2017 Mar; 42(3):833-841. PubMed ID: 27688063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.
    Deng J; Fishbein MH; Rigsby CK; Zhang G; Schoeneman SE; Donaldson JS
    Pediatr Radiol; 2014 Nov; 44(11):1379-87. PubMed ID: 24840769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.
    Sofue K; Mileto A; Dale BM; Zhong X; Bashir MR
    J Magn Reson Imaging; 2015 Nov; 42(5):1281-90. PubMed ID: 25920074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease.
    Furuta A; Ito K; Fujita T; Koike S; Shimizu A; Matsunaga N
    AJR Am J Roentgenol; 2004 Jul; 183(1):157-62. PubMed ID: 15208131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
    Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
    Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
    J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study.
    Fischer MA; Gnannt R; Raptis D; Reiner CS; Clavien PA; Schmidt B; Leschka S; Alkadhi H; Goetti R
    Invest Radiol; 2011 Jun; 46(6):351-8. PubMed ID: 21263329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency Selective Non-Linear Blending to Improve Image Quality in Liver CT.
    Bongers MN; Bier G; Kloth C; Schabel C; Fritz J; Nikolaou K; Horger M
    Rofo; 2016 Dec; 188(12):1163-1168. PubMed ID: 27907941
    [No Abstract]   [Full Text] [Related]  

  • 49. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Jung J; Han A; Madamba E; Bettencourt R; Loomba RR; Boehringer AS; Andre MP; Erdman JW; O'Brien WD; Fowler KJ; Sirlin CB; Loomba R
    Radiology; 2022 Jul; 304(1):75-82. PubMed ID: 35348378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.
    Han A; Andre MP; Deiranieh L; Housman E; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    J Ultrasound Med; 2018 Aug; 37(8):1913-1927. PubMed ID: 29359454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mixed Imaging on Port-Venous Phase of Contrast-Enhanced Dual-Source Dual-Energy Computed Tomography: A Measurement Method Based on Couinaud Segments.
    Jiang C; Shen L; Xia L; Sun S; Fang W; Feng Q; Dong H; Ma Z
    J Comput Assist Tomogr; 2018; 42(6):944-953. PubMed ID: 30407245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease.
    Torkzaban M; Wessner CE; Halegoua-DeMarzio D; Rodgers SK; Lyshchik A; Nam K
    Acad Radiol; 2023 Sep; 30(9):1838-1845. PubMed ID: 36586759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lobar hepatic steatosis: Association with portal flow hemodynamics evaluated by multiphasic dynamic contrast-enhanced CT.
    Kawano Y; Tanabe M; Kameda F; Higashi M; Ihara K; Tanabe M; Inoue A; Kobayashi T; Ueda T; Ito K
    Eur J Radiol; 2023 Mar; 160():110688. PubMed ID: 36630843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reproducibility Analysis of Iodine Concentrations of Abdominal Parenchymal Organs Based on Spectral CT].
    Meng QL; Xu H; Zong LX; Liu MQ; Chen ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):57-62. PubMed ID: 33663664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference.
    Heba ER; Desai A; Zand KA; Hamilton G; Wolfson T; Schlein AN; Gamst A; Loomba R; Sirlin CB; Middleton MS
    J Magn Reson Imaging; 2016 Feb; 43(2):398-406. PubMed ID: 26201284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.